Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia
<b>Introduction</b><b>:</b> Ethiopia introduced a second dose of measles-containing vaccine (MCV2) in 2019 to provide further protection against measles and further progress toward elimination. However, the sub-optimal coverage of both MCV1 and MCV2 suggest challenges with va...
Saved in:
| Main Authors: | Kalkidan Solomon, Brooke N. Aksnes, Abyot Bekele Woyessa, Chala Gari Sadi, Almea M. Matanock, Monica P. Shah, Paulos Samuel, Bekana Tolera, Birhanu Kenate, Abebe Bekele, Tesfaye Deti, Getachew Wako, Amsalu Shiferaw, Yohannes Lakew Tefera, Melkamu Ayalew Kokebie, Tatek Bogale Anbessie, Habtamu Teklie Wubie, Aaron Wallace, Ciara E. Sugerman, Mirgissa Kaba |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-06-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/7/702 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends of the second measles vaccine (MCV2) over time after its launch as part of routine immunization in Nigeria: a brief research report
by: Ryoko Sato
Published: (2024-10-01) -
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? – evidence from Nigeria
by: Ryoko Sato
Published: (2024-12-01) -
Gaps in measles surveillance and vaccination data in India
by: Sirshendu Chaudhuri, et al.
Published: (2025-04-01) -
A real-world study on the changing characteristics of measles antibodies in premature infants in China
by: Mingyan Li, et al.
Published: (2024-12-01) -
Measles immunity in different population groups
by: M. A. Belopolskaya, et al.
Published: (2020-03-01)